Germany · Delayed Price · Currency is EUR Heidelberg Pharma AG Statistics
Total Valuation
ETR:HPHA has a market cap or net worth of EUR 97.31 million. The enterprise value is 77.77 million.
| Market Cap | 97.31M |
| Enterprise Value | 77.77M |
Important Dates
The next estimated earnings date is Wednesday, March 24, 2027.
| Earnings Date | Mar 24, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
ETR:HPHA has 46.78 million shares outstanding. The number of shares has decreased by -2.91% in one year.
| Current Share Class | 46.78M |
| Shares Outstanding | 46.78M |
| Shares Change (YoY) | -2.91% |
| Shares Change (QoQ) | -5.73% |
| Owned by Insiders (%) | 2.31% |
| Owned by Institutions (%) | 0.73% |
| Float | 9.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.24
| Current Ratio | 4.24 |
| Quick Ratio | 2.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6,569.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -42.36% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -93.97% |
| Weighted Average Cost of Capital (WACC) | 8.39% |
| Revenue Per Employee | 282,370 |
| Profits Per Employee | -906,166 |
| Employee Count | 33 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 0.14 |
Taxes
In the past 12 months, ETR:HPHA has paid 1.48 million in taxes.
| Income Tax | 1.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.47% in the last 52 weeks. The beta is 0.76, so ETR:HPHA's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -32.47% |
| 50-Day Moving Average | 2.41 |
| 200-Day Moving Average | 2.69 |
| Relative Strength Index (RSI) | 35.46 |
| Average Volume (20 Days) | 6,990 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:HPHA had revenue of EUR 9.32 million and -29.90 million in losses. Loss per share was -0.66.
| Revenue | 9.32M |
| Gross Profit | 7.54M |
| Operating Income | -32.83M |
| Pretax Income | -28.43M |
| Net Income | -29.90M |
| EBITDA | -32.57M |
| EBIT | -32.83M |
| Loss Per Share | -0.66 |
Balance Sheet
The company has 19.84 million in cash and 298,958 in debt, with a net cash position of 19.54 million or 0.42 per share.
| Cash & Cash Equivalents | 19.84M |
| Total Debt | 298,958 |
| Net Cash | 19.54M |
| Net Cash Per Share | 0.42 |
| Equity (Book Value) | -19.32M |
| Book Value Per Share | -0.44 |
| Working Capital | 25.51M |
Cash Flow
In the last 12 months, operating cash flow was -19.14 million and capital expenditures 28,973, giving a free cash flow of -19.11 million.
| Operating Cash Flow | -19.14M |
| Capital Expenditures | 28,973 |
| Depreciation & Amortization | 259,844 |
| Net Borrowing | -182,275 |
| Free Cash Flow | -19.11M |
| FCF Per Share | -0.41 |
Margins
| Gross Margin | 80.93% |
| Operating Margin | -352.32% |
| Pretax Margin | -305.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ETR:HPHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.91% |
| Shareholder Yield | 2.91% |
| Earnings Yield | -31.57% |
| FCF Yield | -19.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.
| Last Split Date | Nov 7, 2017 |
| Split Type | Forward |
| Split Ratio | 1.0464082038 |
Scores
ETR:HPHA has an Altman Z-Score of -12.79 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.79 |
| Piotroski F-Score | 2 |